This inventor holds 6 USPTO granted patents. Top assignee: Sterling Drug Inc.. Active years: 1976-1979.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976-1979
Title: The Innovative Contributions of Andrew W. Zalay
Introduction
Andrew W. Zalay is a notable inventor based in Albany, NY (US). He has made significant contributions to the field of antibacterial agents through his innovative patents. With a total of 6 patents, Zalay's work has had a meaningful impact on pharmaceutical research and development.
Latest Patents
One of Zalay's latest patents includes the development of 1-Alkyl-1,4-dihydro-4-oxo-7-triazenyl-3-quinolinecarboxylic acids. These compounds are recognized for their utility as antibacterial agents. The patent details the preparation of these compounds by reacting lower-alkyl 7-amino-1-R-1,4-dihydro-4-oxo-3-quinolinecarboxylate with a mineral acid and an alkali nitrite in an aqueous medium. This process produces the corresponding diazonium salt, which is then reacted with an amine to yield the desired antibacterial compounds. Another significant patent involves the preparation of 3-(pyridinyl)-2-cyclohexene-1-ones, which are useful in synthesizing known antibacterial agents.
Career Highlights
Zalay is currently associated with Sterling Drug Inc., where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in advancing the development of new antibacterial agents, showcasing his expertise and dedication to improving healthcare.
Collaborations
Throughout his career, Zalay has collaborated with notable colleagues, including Malcolm R. Bell and Karl O. Gelotte. These collaborations have further enriched his research and contributed to the success of his inventions.
Conclusion
Andrew W. Zalay's contributions to the field of antibacterial agents through his patents highlight his innovative spirit and commitment to advancing medical science. His work continues to influence the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
